Citation:Aupérin A, Le Péchoux C, Pignon JP, Koning C, Jeremic B, Clamon G, et al 2006

From Cancer Guidelines Wiki

Citation


Aupérin A, Le Péchoux C, Pignon JP, Koning C, Jeremic B, Clamon G, et al. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 2006 Mar;17(3):473-83 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500915.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?Dr Margot Lehman MBBS FRANZCR GDPcompleted
What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?Dr Shawgi Sukumarancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
  2. What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?